reserpine has been researched along with quinine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (53.57) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Gambaryan, S; Gorboulev, V; Gründemann, D; Koepsell, H; Veyhl, M | 1 |
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
| Pajeva, IK; Wiese, M | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gomaa, CS; Taha, AM | 1 |
| Beck, WT; Cirtain, MC; Felsted, RL; Glover, CJ; Safa, AR | 1 |
| Schollmeyer, P | 1 |
| Okla, J | 1 |
| Inouye, H; Takeda, Y; Ueda, S | 1 |
| Behnsen, G; Kühn, L; Pfeifer, S | 1 |
| Shine, KI | 1 |
| Quadbeck, G | 1 |
| Müller, WC | 1 |
| LUSTINEC, K | 1 |
| CIMELLARO, M; FERRARI, B | 1 |
| SOLLA, E | 1 |
| ARENA, JM | 1 |
| Bromek, E; Daniel, WA; Gołembiowska, K; Haduch, A | 1 |
3 review(s) available for reserpine and quinine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Administration of some drugs to pregnant or breast feeding women].
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anticoagulants; Antineoplastic Agents; Antithyroid Agents; Barbiturates; Breast Feeding; Contraceptives, Oral; Diethylstilbestrol; Drug-Related Side Effects and Adverse Reactions; Female; Fetal Death; Fetus; Humans; Hypoglycemic Agents; Infant, Newborn; Lactation; Maternal-Fetal Exchange; Meprobamate; Molecular Weight; Nicotine; Nitrofurantoin; Permeability; Placenta; Pregnancy; Quinine; Reserpine; Salicylates; Sulfonamides | 1972 |
[CONTRIBUTION TO THE STUDY OF UTERINE DYSKINESIAS AND THEIR TREATMENT].
Topics: Adenosine Triphosphate; Dyskinesias; Dystocia; Ergotamine; Female; Hexoses; Humans; Insulin; Meperidine; Muscle Relaxants, Central; Oxytocin; Pregnancy; Quinine; Relaxin; Reserpine; Sparteine; Sympathomimetics; Thiamine; Uterus | 1963 |
25 other study(ies) available for reserpine and quinine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Drug excretion mediated by a new prototype of polyspecific transporter.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cations; Cells, Cultured; DNA, Complementary; Intestinal Mucosa; Kidney Tubules, Proximal; Liver; Membrane Proteins; Molecular Sequence Data; Organic Cation Transporter 1; Pharmacokinetics; Recombinant Proteins; RNA, Messenger; Xenopus | 1994 |
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine | 2002 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Analysis of alkaloid mixtures by charge-transfer complexation.
Topics: Alkaloids; Belladonna Alkaloids; Chemical Phenomena; Chemistry; Codeine; Ephedrine; Ergotamine; Papaverine; Quinine; Reserpine; Solutions; Sparteine; Spectrophotometry, Ultraviolet; Tablets; Tropanes | 1976 |
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Topics: Affinity Labels; Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Survival; Chloroquine; Drug Interactions; Drug Resistance; Humans; Indoles; Leukemia; Membrane Glycoproteins; Photochemistry; Quinacrine; Quinine; Reserpine; Verapamil; Vinblastine; Vinca Alkaloids; Vindesine; Yohimbine | 1988 |
[Cardiac rhythm disorders. 2. Therapy].
Topics: Adrenergic alpha-Antagonists; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Cardiac Complexes, Premature; Digitalis Glycosides; Electric Countershock; Heart Block; Heart Massage; Humans; Hydantoins; Lidocaine; Metaproterenol; Procainamide; Quinine; Reserpine; Tachycardia, Paroxysmal; Ventricular Fibrillation | 1971 |
Drugs in breast milk.
Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents; Antithyroid Agents; Aspirin; Atropine; Caffeine; Chloramphenicol; Chlorothiazide; Contraceptives, Oral; Ergot Alkaloids; Ethanol; Female; Humans; Hypnotics and Sedatives; Methadone; Milk, Human; Nalidixic Acid; Narcotics; Penicillins; Quinine; Reserpine; Sulfonamides; Tetracycline | 1974 |
[On the biosynthesis of vinca as well as cinchona alkaloids: incorporation of swerosids in reserpinine and quinine].
Topics: Alkaloids; Cinchona; Plants; Plants, Medicinal; Quinine; Rauwolfia; Reserpine | 1969 |
[Stability of alkaloids in organic solvents. 1].
Topics: Acetone; Alkaloids; Atropine; Benzene; Caffeine; Chloroform; Codeine; Darkness; Drug Stability; Ethanol; Light; Methanol; Morphine; Noscapine; Papaverine; Physostigmine; Pilocarpine; Quinine; Radiation; Reserpine; Scopolamine; Solvents; Temperature; Thebaine | 1972 |
Contractile calcium in rabbit myocardium: observations with nicotine and quinine.
Topics: Animals; Biomechanical Phenomena; Buffers; Caffeine; Calcium; Calcium Isotopes; Heart Septum; Hydrogen-Ion Concentration; Lanthanum; Muscle Contraction; Myocardium; Nicotine; Perfusion; Quinine; Rabbits; Reserpine | 1973 |
Drug influence on the barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Carbon Isotopes; Chlorpromazine; Coloring Agents; Glucose; Mice; Phosphates; Quinine; Radioisotopes; Rats; Reserpine; Sodium Chloride; Sodium Isotopes | 1968 |
[Administration of drugs during pregnancy].
Topics: Abnormalities, Drug-Induced; Anti-Bacterial Agents; Anticoagulants; Contraceptives, Oral; Cortisone; Drug Therapy; Female; Fetal Diseases; Gestational Age; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Morphinans; Pharmaceutical Preparations; Pregnancy; Quinine; Reserpine; Sulfonamides | 1969 |
The effect of some drugs on oxygen consumption in rats under basal conditions and during cold stress.
Topics: Animals; Barbiturates; Bis-Trimethylammonium Compounds; Chloral Hydrate; Chlorpromazine; Cold Temperature; Dihydroergotoxine; Ergot Alkaloids; Mephenesin; Metabolism; Oxygen Consumption; Promethazine; Pyridines; Quinine; Rats; Reserpine; Stress, Physiological; Urethane; Yohimbine | 1962 |
[OUR PRINCIPLES OF THERAPY IN MEDICATION IN LABOR (FURTHER OBSERVATIONS ON SERPASIL)].
Topics: Ergonovine; Female; Humans; Labor, Obstetric; Papaverine; Pharmacology; Pregnancy; Quinine; Reserpine; Sparteine | 1964 |
REPORT FROM THE DUKE UNIVERSITY POISON CONTROL CENTER. DRUG DANGERS (MATERNAL MEDICATION) TO THE FETUS.
Topics: Abnormalities, Drug-Induced; Aminopterin; Anti-Bacterial Agents; Antimetabolites; Chloramphenicol; Cortisone; Female; Fetal Diseases; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Iodides; Iodine Isotopes; North Carolina; Opium; Oxygen; Poison Control Centers; Pregnancy; Pregnancy Complications; Progestins; Quinine; Reserpine; Sulfonamides; Testosterone; Thalidomide; Thiouracil; Toxicology; Universities; Vitamin K | 1964 |
Cytochrome P450 mediates dopamine formation in the brain in vivo.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Analgesics, Non-Narcotic; Animals; Brain; Cytochrome P-450 Enzyme System; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Male; Microdialysis; Models, Statistical; Quinine; Rats; Rats, Wistar; Reserpine; Tyramine | 2011 |